DexCom
DXCM
#887
Rank
โ‚ฌ23.97 B
Marketcap
62,13ย โ‚ฌ
Share price
0.28%
Change (1 day)
-16.39%
Change (1 year)

Revenue for DexCom (DXCM)

Revenue in 2026 (TTM): โ‚ฌ4.11 Billion

According to DexCom's latest financial reports the company's current revenue (TTM ) is โ‚ฌ4.15 Billion. In 2025 the company made a revenue of โ‚ฌ3.96 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ3.87 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DexCom from 2006 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ4.11 B3.67%
2025 โ‚ฌ3.96 B2.4%
2024 โ‚ฌ3.87 B18.28%
2023 โ‚ฌ3.27 B20.79%
2022 โ‚ฌ2.71 B25.47%
2021 โ‚ฌ2.16 B38.02%
2020 โ‚ฌ1.56 B18.89%
2019 โ‚ฌ1.31 B46.11%
2018 โ‚ฌ0.90 B50.59%
2017 โ‚ฌ0.59 B9.87%
2016 โ‚ฌ0.54 B48.24%
2015 โ‚ฌ0.36 B72.51%
2014 โ‚ฌ0.21 B83.95%
2013 โ‚ฌ0.11 B53.46%
2012 โ‚ฌ75.49 M28.56%
2011 โ‚ฌ58.72 M60.63%
2010 โ‚ฌ36.56 M76.41%
2009 โ‚ฌ20.72 M194.54%
2008 โ‚ฌ7.03 M122.05%
2007 โ‚ฌ3.16 M92.72%
2006 โ‚ฌ1.64 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ83.03 B 1,900.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ38.89 B 836.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚ฌ30.57 B 636.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
โ‚ฌ18.89 B 355.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
โ‚ฌ5.22 B 25.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
โ‚ฌ0.87 B-78.94%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
โ‚ฌ2.33 B-43.66%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
โ‚ฌ2.77 B-33.15%๐Ÿ‡บ๐Ÿ‡ธ USA